 |
 |

Biological Defense Research: Charting a Safer Course
Jay A. Jacobson, MD;
Barbara Hatch Rosenberg, PhD
JAMA. 1989;262(5):675-676.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
THE ARMY'S research on biological agents has escalated dramatically since 1980 and raised concerns in the scientific and medical communities about its propriety, utility, and safety. In an article in this issue of THE JOURNAL regarding chemical and biological warfare, Orient1 asks whether defenses should be researched. Defenses are, of course, being researched, but some of this research may undermine the 1972 Biological and Toxin Weapons Convention, which bans the use and development of biological weapons. We will comment on some aspects of the current US Biological Defense Research Program and suggest ways that physicians can be sure that research on biological agents, if it is necessary, is safe, appropriate, and likely to decrease rather than increase the threat of a biological arms race. We propose changes in responsibility for some biological defense research, more openness in the conduct of research, and reinforcement of the 1972 treaty.
The basis
. . . [Full Text PDF of this Article]
Author Affiliations
From the Department of Internal Medicine, University of Utah, and the Division of Infectious Diseases, Latter-Day Saints Hospital, Salt Lake City (Dr Jacobson) and the Memorial-Sloan Kettering Cancer Center, Walker Laboratory, Rye, NY (Dr Rosenberg).
Footnotes
Reprint requests to the Division of Infectious Diseases, Latter-Day Saints Hospital, Eighth Avenue and C Street, Salt Lake City, UT 84143 (Dr Jacobson).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|